Suppr超能文献

推进施万细胞移植用于脊髓损伤修复面临的挑战。

Challenges in advancing Schwann cell transplantation for spinal cord injury repair.

作者信息

Guest James D, Santamaria Andrea J, Solano Juan P, de Rivero Vaccari Juan P, Dietrich William D, Pearse Damien D, Khan Aisha, Levi Allan D

机构信息

The Miami Project to Cure Paralysis and Neurological Surgery, Miller School of Medicine, University of Miami, Miami, FL, USA.

The Miami Project to Cure Paralysis, Miller School of Medicine, University of Miami, Miami, FL, USA.

出版信息

Cytotherapy. 2025 Jan;27(1):36-50. doi: 10.1016/j.jcyt.2024.08.005. Epub 2024 Aug 23.

Abstract

BACKGROUND AIMS

In this article we aimed to provide an expert synthesis of the current status of Schwann cell (SC)therapeutics and potential steps to increase their clinical utility.

METHODS

We provide an expert synthesis based on preclinical, clinical and manufacturing experience.

RESULTS

Schwann cells (SCs) are essential for peripheral nerve regeneration and are of interest in supporting axonal repair after spinal cord injury (SCI). SCs can be isolated and cultivated in tissue culture from adult nerve biopsies or generated from precursors and neural progenitors using specific differentiation protocols leading to expanded quantities. In culture, they undergo dedifferentiation to a state similar to "repair" SCs. The known repertoire of SC functions is increasing beyond axon maintenance, myelination, and axonal regeneration to include immunologic regulation and the release of potentially therapeutic extracellular vesicles. Recently, autologous human SC cultures purified under cGMP conditions have been tested in both nerve repair and subacute and chronic SCI clinical trials. Although the effects of SCs to support nerve regeneration are indisputable, their efficacy for clinical SCI has been limited according to the outcomes examined.

CONCLUSIONS

This review discusses the current limitations of transplanted SCs within the damaged spinal cord environment. Limitations include limited post-transplant cell survival, the inability of SCs to migrate within astrocytic parenchyma, and restricted axonal regeneration out of SC-rich graft regions. We describe steps to amplify the survival and integration of transplanted SCs and to expand the repertoire of uses of SCs, including SC-derived extracellular vesicles. The relative merits of transplanting autologous versus allogeneic SCs and the role that endogenous SCs play in spinal cord repair are described. Finally, we briefly describe the issues requiring solutions to scale up SC manufacturing for commercial use.

摘要

背景与目的

在本文中,我们旨在对施万细胞(SC)治疗的现状以及提高其临床应用价值的潜在步骤进行专家综述。

方法

我们基于临床前、临床及生产经验进行专家综述。

结果

施万细胞对周围神经再生至关重要,在支持脊髓损伤(SCI)后的轴突修复方面也备受关注。施万细胞可从成人神经活检组织中分离并在组织培养中培养,或使用特定分化方案从前体和神经祖细胞生成,从而实现数量的扩增。在培养过程中,它们会去分化为类似于“修复”施万细胞的状态。施万细胞已知的功能范围正在不断扩大,不仅包括轴突维持、髓鞘形成和轴突再生,还包括免疫调节以及释放具有潜在治疗作用的细胞外囊泡。最近,在cGMP条件下纯化的自体人施万细胞培养物已在神经修复以及亚急性和慢性脊髓损伤的临床试验中进行了测试。尽管施万细胞支持神经再生的作用无可争议,但根据所检查的结果,其对临床脊髓损伤的疗效有限。

结论

本综述讨论了在受损脊髓环境中移植施万细胞目前存在的局限性。这些局限性包括移植后细胞存活率有限、施万细胞无法在星形胶质细胞实质内迁移以及轴突从富含施万细胞的移植区域向外再生受限。我们描述了提高移植施万细胞存活率和整合能力以及扩大施万细胞用途范围(包括施万细胞衍生的细胞外囊泡)的步骤。还描述了移植自体与异体施万细胞的相对优点以及内源性施万细胞在脊髓修复中所起的作用。最后,我们简要描述了为扩大施万细胞生产规模以供商业使用而需要解决的问题。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验